Transbiomed Overview
- Founded
- 2007
- Status
- Acquired/Merged
- Latest Deal Type
- M&A
Transbiomed General Information
Description
Developer of non-invasive molecular diagnostic therapies. The company is focused on biomarker discovery and development through to industrial prototyping, final product design and pivotal clinical trials, then licensing its products to large pharmaceutical companies for commercialization.
Contact Information
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Discovery Tools (Healthcare)
Acquirer
Primary Office
- Parc Científic de Barcelona, Edifici Helix
- Baldiri Reixac, 15-21
- 08028 Barcelona
- Spain
+34 934 00 00 00
Transbiomed Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 2. Merger/Acquisition | 08-Feb-2013 | 00.000 | Completed | Product Development | ||
| 1. Early Stage VC | 17-Feb-2011 | 00.000 | 00.000 | Completed | Product Development |
Transbiomed Executive Team (1)
| Name | Title | Board Seat | Contact Info |
|---|---|---|---|
| Julia Winter | Chief Executive Officer |
Transbiomed Former Investors (3)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|---|---|---|---|---|
| ACC1Ó | Government | Minority | 000 0000 | 000000 0 | |
| Inveready Technology Investment Group | Venture Capital | Minority | 000 0000 | 000000 0 | |
| Ministry of Science and Innovation | Government | Minority | 000 0000 | 000000 0 |